Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Other Routine +

OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX

Charlotte's Web Upgrades to OTCQX as BAT Debt Conversion Stabilizes Balance Sheet

Executive Summary
  • Charlotte's Web Holdings Inc. successfully upgraded its trading tier from the OTCQB Venture Market to the OTCQX Best Market effective April 30, 2026.
  • The company begins trading under the symbol "CWBHF" on the OTCQX.
  • Qualification criteria met include high financial standards, best practice corporate governance, and compliance with securities laws.
  • The upgrade provides U.S. investors access to current financial disclosure and Real-Time Level 2 quotes via the OTC Markets website.
  • This follows the March 2026 announcement of a transformative transaction with BAT DE Investments involving debt conversion and equity injection.
Material Impact
  • The OTCQX upgrade is a validation of the company's improved financial standing following the March 2026 BAT transaction which eliminated ~$65M in debt.
  • While positive for liquidity and institutional visibility, it does not fundamentally alter revenue streams or operational capacity compared to the prior financing news.
  • The market likely anticipated this upgrade given the balance sheet cleanup disclosed in Q4 2025 earnings; therefore, the immediate price impact is expected to be muted relative to the March announcement.
  • It confirms management's ability to meet higher governance standards post-restructuring, reducing regulatory risk perception for OTC investors.
CWEB · Price
Company Overview
  • Charlotte's Web is a leading hemp-derived CBD brand transitioning into pharmaceutical development via its subsidiary DeFloria.
  • Flagship Project: DeFloria AJA001 oral solution for irritability associated with autism spectrum disorder (ASD).
  • The company has received FDA clearance to proceed to Phase 2 trials, holding exclusive manufacturing rights and ~33% equity in DeFloria.
  • Operational focus includes internalization of Brightside gummy production (~75% in-house by 2026) and expansion into sleep-support categories (mushroom gummies, THC/CBN blends).
Read the original news release →

More from CHARLOTTE'S WEB HOLDINGS, INC.